The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial

被引：0
|
作者：
Sahar Foshati
Maryam Poursadeghfard
Zahra Heidari
Reza Amani
机构：
[1] Shiraz University of Medical Sciences,Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition and Food Sciences
[2] Shiraz University of Medical Sciences,Clinical Neurology Research Center
[3] Isfahan University of Medical Sciences,Department of Biostatistics and Epidemiology, School of Health
[4] Isfahan University of Medical Sciences,Department of Clinical Nutrition, School of Nutrition and Food Science
来源：
BMC Complementary Medicine and Therapies | / 23卷
关键词：
Abdominal pain; Bloating; Constipation; Ginger; Multiple sclerosis; Nausea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A double-blind, randomized, placebo-controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing-remitting multiple sclerosis
    Fox, Robert J.
    Wiendl, Heinz
    Wolf, Christian
    De Stefano, Nicola
    Sellner, Johann
    Gryb, Viktoriia
    Rejdak, Konrad
    Bozhinov, Plamen Stoyanov
    Tomakh, Nataliya
    Skrypchenko, Iryna
    Muehler, Andreas R.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2022, 9 (07): : 977 - 987
  • [22] A Double-Blind, Randomized, Placebo-Controlled Trial of Simvastatin as Add-On Therapy to Interferon-Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Sorensen, Per Soelberg
    Lycke, Jan
    Eralinna, Juha-Pekka
    Edland, Astrid
    Wu, Xingchen
    Frederiksen, Jette L.
    Oturai, Annette Bang
    Malmestrom, Clas
    Stenager, Egon
    Sperling, Bjorn
    NEUROLOGY, 2011, 76 (09) : A546 - A547
  • [23] CONCERTO: a placebo-controlled trial of oral laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Boyko, A.
    Vermersch, P.
    Ziemssen, T.
    Montalban, X.
    Lublin, F. D.
    Sasson, N.
    Dadon, Y.
    Steinerman, J. R.
    Knappertz, V.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 74 - 75
  • [24] Baseline Characteristics of Patients in the DEFINE Trial: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Study of BG-12 in Relapsing-Remitting Multiple Sclerosis
    Gold, Ralf
    Arnold, Douglas
    Kappos, Ludwig
    Bar-Or, Amit
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Yang, Minhua
    Dawson, Katherine
    NEUROLOGY, 2010, 74 (09) : A546 - A547
  • [25] A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Safety and Efficacy of Daclizumab HYP Monotherapy in Relapsing-Remitting Multiple Sclerosis: Primary Results of the SELECT Trial
    Gold, Ralf
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Havrdova, Eva
    Montalban, Xavier
    Radue, Ernst-Wilhelm
    Stefoski, Dusan
    Robinson, Randy
    Riester, Katherine
    Elkins, Jacob
    O'Neill, Gilmore
    NEUROLOGY, 2012, 78
  • [26] The efficacy of cladribine in relapsing-remitting multiple sclerosis: Clinical data from a randomized, double-blind, placebo-controlled, 18-month, phase II trial
    Sipe, Jack
    Gardner, Jason
    Beutler, Ernest
    NEUROLOGY, 2008, 70 (11) : A90 - A91
  • [27] A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of daclizumab HYP monotherapy in relapsing-remitting multiple sclerosis: primary results of the SELECT trial
    Giovannoni, G.
    Gold, R.
    Selmaj, K.
    Havrdova, E.
    Montalban, X.
    Radue, E. W.
    Stefoski, D.
    Robinson, R.
    Riester, K.
    Elkins, J.
    O'Neill, G.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S508 - S509
  • [28] Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Kouchaki, Ebrahim
    Tamtaji, Omid Reza
    Salami, Mahmoud
    Bahmani, Fereshteh
    Kakhaki, Reza Daneshvar
    Akbari, Elmira
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Asemi, Zatollah
    CLINICAL NUTRITION, 2017, 36 (05) : 1245 - 1249
  • [29] Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 9-month double-blind active extension of the multicenter, randomized, double-blind, parallel-group placebo-controlled study
    Comi, Giancarlo
    Abramsky, O.
    Arbizu, T.
    Boyko, Alexey
    Gold, Ralf
    Havrdova, Eva
    Komoly, Samuel
    Selmaj, Krzysztof
    Sharrack, Basil
    Filippi, Massimo
    MULTIPLE SCLEROSIS, 2008, 14 : S37 - S38
  • [30] Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial
    Togha, Mansoureh
    Karvigh, Sanaz Ahmadi
    Nabavi, Masoud
    Moghadam, Nahid Beladi
    Harirchian, Mohammad Hossein
    Sahraian, Mohammad Ali
    Enzevaei, Anahita
    Nourian, Alireza
    Ghanaati, Hossein
    Firouznia, Kavous
    Jannati, Ali
    Shekiba, Majid
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (07) : 848 - 854
12345